IV Induction and Maintenance Agent
Pregnancy: Use with caution — crosses placenta; neonatal CNS depression if given at delivery
Propofol
Brand names: Diprivan
Adult dose
Dose: 1.5-2.5 mg/kg IV induction; 4-12 mg/kg/hr infusion (TIVA); 0.3-4 mg/kg/hr (sedation)
Route: Intravenous
Frequency: Continuous infusion (TIVA/sedation); bolus (induction)
Max: Titrated to effect; sedation: 4 mg/kg/hr
Reduce induction dose to 1-1.5 mg/kg in elderly or ASA 3/4. Give slowly (avoid pain on injection — use antecubital fossa or pre-treat with lidocaine 20-40 mg IV). Shake before use (emulsion)
Paediatric dose
Dose: 2.5-3.5 mg/kg IV (induction); 9-15 mg/kg/hr (TIVA) mg/kg
Route: IV
Frequency: Bolus (induction); infusion (maintenance)
Max: Avoid prolonged infusions in children — PRIS risk
Induction: child 1 month to 17 years: 2.5-3.5 mg/kg slow IV. NOT licensed for sedation in ICU patients under 16 due to propofol infusion syndrome (PRIS) risk
Dose adjustments
Renal
No dose adjustment required
Hepatic
No dose adjustment required; context-sensitive half-time increases in severe hepatic impairment
Paediatric weight-based calculator
Induction: child 1 month to 17 years: 2.5-3.5 mg/kg slow IV. NOT licensed for sedation in ICU patients under 16 due to propofol infusion syndrome (PRIS) risk
Clinical pearls
- PRIS (propofol infusion syndrome): life-threatening metabolic complication at high doses (above 5 mg/kg/hr) for prolonged periods — metabolic acidosis, rhabdomyolysis, hyperkalaemia, cardiac failure; switch to alternative sedation if PRIS suspected
- Rapid redistribution from brain to peripheral tissues explains short duration of action (5-10 min after single bolus) — context-sensitive half-time increases with prolonged infusions
- Lipid emulsion: 1% propofol provides 1.1 kcal/mL from fat — factor into nutritional calculations in ICU; change infusion line every 12 hours (infection risk from lipid medium)
- Reduces CMRO2, ICP, and cerebral blood flow — favourable for neuroanaesthesia; however hypotension from propofol can compromise CPP
- Antiemetic properties at sub-anaesthetic doses (10-20 mg bolus) — used as rescue antiemetic in PACU
Contraindications
- Allergy to soya, peanut, or egg (emulsion contains soya oil and egg lecithin)
- ICU sedation in children under 16 (PRIS risk)
Side effects
- Hypotension (vasodilation — most significant)
- Apnoea on induction
- Pain on IV injection
- Propofol infusion syndrome (PRIS — rare; metabolic acidosis, rhabdomyolysis, cardiac failure; at doses above 5 mg/kg/hr for more than 48 hours)
- Urine discolouration (green — harmless)
- Bradycardia
Interactions
- Opioids and benzodiazepines (additive CNS/respiratory depression — synergistic; reduce propofol dose)
- Muscle relaxants (no direct interaction)
- Antihypertensives (additive hypotension)
Monitoring
- Blood pressure (continuous intraoperative)
- Respiratory rate / SpO2
- Level of sedation (Ramsay/RASS score in ICU)
- Triglycerides (prolonged ICU use)
- Signs of PRIS (pH, lactate, CK)
Reference: BNFc; BNF 90; AAGBI Safety Guidelines; Diprivan SPC; Vasile et al. (PRIS Review). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Ramsay Sedation Scale · Sedation
- Ramsay Sedation Scale · Sedation Assessment
- Bishop Score · Labour & Delivery
- Modified Bishop Score for Cervical Ripeness · Labour & Delivery
- Bishop Score (Cervical Ripeness for Induction) · Labour and Delivery
- Paediatric Maintenance Fluid (Holliday-Segar) · Paediatric Calculations
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH